Earnings Report

Defense contractors continued to operate relatively unscathed through the stay-at-home orders due to the COVID-19 pandemic after being deemed essential businesses.

Cigarette shipments fell 18% in the quarter, dragged down in part by weakness in South and Southeast Asia, where volumes were off 28% from last year.

Coca-Cola profit plunged 32 percent as resetaurant sales suffered from COVID-19 lockdowns.

Revenue from the cloud business increased 30 percent to $6.3 billion

Investors dipped back into stocks, driving the Nasdaq to its 28th record high of 2020.

Halliburton lost $1.7 billion in the second quarter as the coronavirus pandemic provided difficult business conditions.

86 S&P 500 companies report earnings next week and 8 Dow members.

BlackRock reported a 22 percent jump in second-quarter profit.

COVID-19 has Netflix watchers glued to the streaming giant but the pace may not be sustainable.

Initial jobless claims for the week ended July 10 totaled 1.3 million, slightly higher than the 1.25 million that were expected.

Charles Schwab added 552,000 new brokerage accounts in the second quarter as total client assets swelled 11 percent to $4.11 trillion.

Revenue from the company's diagnostics segment rose 23% to $857 million as demand surged for Covid-19 tests. Abbott's diagnostics growth was fueled by its sales of both lab-based tests and on-site tests.

Domino's Pizza profit spiked 29 percent in the second quarter as consumers ordered more pizza pies while sheltering at home during the COVID-19 pandemic.

Consumer health sales fell 7 percent from a year ago to $3.3 billion as consumers bought fewer skin health and beauty products while sheltering at home during the COVID-19 pandemic.

Morgan Stanley posted a 45% rise in quarterly profit on Thursday, driven by strong trading gains as the coronavirus pandemic whipsawed global financial markets since March.

Net income of $3.5 billion, or 37 cents a share, still topped the 27-cent average estimate from analysts surveyed by Refinitiv. Both JPMorgan Chase and Citigroup posted double-digit profit declines earlier this week after shoring up reserves.

Jobless claims, retail sales and several earnings reports will dictate how the market trades

Moderna's COVID-19 vaccine produced “binding anitbodies” in a Phase 1 trial, according to the New England Journal of Medicine.

Both the investment banking and trading divisions raked in the highest revenue in years, even as Goldman increased its reserves against potential loan defaults.

Major U.S. banks increased reserves against loan defaults during the COVID-19 pandemic while California backtracked on reopenings.